Transcranial Magnetic Stimulation and Cranial Electrical Stimulation. Number 0. 46. 9Policy. Aetna considers repetitive transcranial magnetic stimulation r. Browse and search thousands of Educational Abbreviations and acronyms in our comprehensive reference resource. Brief Biosketch. Adele Diamond is the Canada Research Chair Professor of Developmental Cognitive Neuroscience at the University of British Columbia in Vancouver. BibMe Free Bibliography Citation Maker MLA, APA, Chicago, Harvard. The Blacktailed Prairie Dog is the largest of the prairie dog species, weighing 700 to 1500 grams and measuring 28 to 33 centimeters from nose to tail Burt and. Authors. Russell A. Barkley, Ph. D, ABPP. Russell A. Barkley, Ph. D., ABPP is a Clinical Professor of Psychiatry at the Virginia Treatment Center. Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Easily share your publications and get. Health Studies. NorQuest College is helping ensure Alberta is prepared to meet the growing need for continuing care and anticipated shortage of continuing care. TMS in a healthcare providers office medically necessary when the following criteria are met Administered by an FDA cleared device and utilized in accordance with the FDA labeled indications and. The member is age 1. The member has a confirmed diagnosis of severe major depressive disorder single or recurrent episode, documented by standardized rating scales that reliably measure depressive symptoms eg, Beck Depression Scale BDI, Hamilton Depression Rating Scale HDRS, Montgomery Asberg Depression Rating Scale MADRS, etc. There is documentation via legible medical records of failure of a trial of a psychotherapy known to be effective in the treatment of major depressive disorder of an adequate frequency and duration, without significant improvement in depressive symptoms, as documented by standardized rating scales that reliably measure depressive symptoms e. Beck Depression Scale BDI, Hamilton Depression Rating Scale HDRS, Montgomery Asberg Depression Rating Scale MADRS, etc. The member is currently receiving or is a candidate for electroconvulsive therapy ECT and r. TMS is considered a less invasive equally effective treatment option e. Case Research Replication. Experience a replication of Cases classic research on mathematical reasoning in children. Courtesy of the University of Alberta. American Psychologist is the official peerreviewed scholarly journal of the American Psychological Association. American Psychologist publishes current and timely. Apa Citation For Alberta Program Of Studies' title='Apa Citation For Alberta Program Of Studies' />TMS should not be utilized and. The member has no contraindications to r. TMS refer to contraindications below and. The member meets one of the following criteria There is documentation via legible medical records of failure of 4 trials of psychopharmacologic agents, including 2 different agent classes, during the current depressive episode or. The member is unable to tolerate a therapeutic dose of medications as evidenced by documentation via legible medical records of 4 trials of psychopharmacologic agents with distinct side effects and. Treatment consists of a maximum of 3. Notes Treatments beyond 3. There is a lack of evidence that persons who fail to respond or become refractory to one brand of r. TMS device will respond to another brand of r. TMS device. Aetna considers r. TMS contraindicated and experimental and investigational in persons with any of the following contraindications to r. TMS because the safety and effectiveness in person with these contraindications has not been established Persons with high alcohol or illicit drug consumption or. The member is suicidal or. The member has a metal implant in or around the head eg, aneurysm coil or clip, metal plate, ocular implant, stent or. The member has neurological conditions eg, cerebrovascular disease, dementia, history of repetitive or severe head trauma, increased intracranial pressure or primary or secondary tumors in the central nervous system or. There is presence of implanted devices, eg, cardiac pacemaker or defibrillator, cochlear implant, deep brain stimulator, implantable infusion pump, spinal cord stimulator, vagus nerve stimulator, etc. The member has a seizure disorderepilepsy or. If the member has severe cardiovascular disease, he has been evaluated and cleared for r. TMS treatment by a cardiologist. Aetna considers r. TMS maintenance therapy for depression to be experimental and investigational because the effectiveness and safety of r. TMS maintenance therapy has not been established. Aetna considers transcranial magnetic stimulation experimental and investigational for the following indications because its value and effectiveness has not been established not an all inclusive list Alzheimers disease. Amyotrophic lateral sclerosis. Anxiety disorders. Auditory verbal hallucinations. Autism. Blepharospasm. Bulimia nervosa. Chronic pain including neuropathic pain e. Communication and swallowing disorders e. Epilepsy including status epilepticusCongenital hemiparesis. Dystonia. Fibromyalgia. Levodopa induced dyskinesia. Migraine. Mood disorders. Neuropathic pain associated with spinal cord injury. Obsessive compulsive disorder. Panic disorder. Parkinson disease. Phantom pain associated with spinal cord injury. Post traumatic stress disorder. Restless legs syndrome. Schizophrenia. Smell and taste dysfunction e. Spasticity. Stroke treatment e. Substance addiction. Tourette syndrome. Tinnitus. Traumatic brain injury. Visual hallucinations after stroke. Aetna considers navigated transcranial magnetic stimulation experimental and investigational for motor function mapping andor treatment planning of neurological diseasesdisorders e. Aetna considers cranial electrical stimulation also known as cerebral electrotherapy, craniofacial electrostimulation, electric cerebral stimulation, electrosleep, electrotherapeutic sleep, transcerebral electrotherapy, transcranial electrotherapy, as well as the Fisher Wallace stimulator formerly known as the Liss Body Stimulator that is used to treat alcoholism experimental and investigational because its value and effectiveness has not been established. It is not covered for any indication, including the following not an all inclusive list Alcoholism. Alzheimers disease. Autism. Chemical dependency. Chronic pain. Dementia. Depression. Disorders of consciousness. Headaches. Fibromyalgia. Mood and sleep disturbances. Neuropathic pain. Parkinson disease. Phantom pain associated with spinal cord injury. Restless legs syndrome. Stroke treatment e. Traumatic brain injury. Visual rehabilitation. Background. Transcranial magnetic stimulation TMS is a non invasive method of induction of a focal current in the brain and transient modulation of the function of the targeted cerebral cortex. This procedure entails placement of an electromagnetic coil on the scalp high intensity electrical current is rapidly turned on and off in the coil through the discharge of capacitors. Depending on stimulation parameters frequency, intensity, pulse duration, stimulation site, repetitive TMS r. TMS to specific cortical regions can either increase or decrease the excitability of the affected brain structures. Transcranial magnetic stimulation has been investigated in the treatment of various psychiatric disorders, especially depression. This procedure is usually carried out in an outpatient setting. In contrast to electroconvulsive therapy, TMS does not require anesthesia or analgesia. Furthermore, it does not affect memory and usually does not cause seizures. However, the available peer reviewed medical literature has not established the effectiveness of r. TMS in the treatment of psychiatric disorders other than major depression. In addition, more research is needed to ascertain the roles of various stimulation parameters of r. TMS for its optimal outcome as well as its long term effectiveness in the treatment of psychiatric disorders. Depression. Martin et al 2. TMS with sham in patients with depression. The authors concluded that current trials are of low quality and provide insufficient evidence to support the use of r. TMS in the treatment of depression. Program Is Too Large Vfp here. This is in accordance with the observations of Fitzgerald and colleagues 2. TMS has a considerable role in neuropsychiatric research. It appears to have considerable potential as a therapeutic tool in depression, and perhaps a role in several other disorders, although widespread application requires larger trials and establishment of sustained response, as well as Gershon et al 2.